Back
ESC Premium Access

Dalcetrapib reduces incident diabetes in patients with recent acute coronary syndrome

Session: Poster Session 7 - Lipids
Topic: Pharmacotherapy
Speaker: Professor G. Schwartz (Aurora, US)
Event: ESC Congress 2019

Congress Presentation

Add to my library

Like

About the speaker

Professor Gregory Schwartz

University of Colorado School of Medicine, Aurora (United States of America)
2 presentations
0 follower

14 more presentations in this session

Proprotein convertase subtilisin/kexin type 9 (PCSK9) plasma levels are associated with the metabolic syndrome in patients with stable coronary artery disease

Speaker: Doctor C. Caselli (Pisa, IT)

Access
Abstract
Slides
Like
Thumbnail

Effects of evolocumab on LDL-C by race and ethnicity: an analysis of double-blind and open-label extension studies

Speaker: Doctor C. Rodriguez (The Bronx, US)

Access
Abstract
Like
Thumbnail

Therapeutic effect of nanoliposomal anti-PCSK9 vaccine on hypercholesterolemia and atherosclerosis in C57BL/6 mice.

Speaker: Professor M. Banach (Lodz, PL)

Access
Abstract
Slides
Like
Thumbnail

Nanoliposomal anti-PCSK9 vaccine induces long-term and safe protection against atherosclerosis in C57BL/6 mouse.

Speaker: Professor M. Banach (Lodz, PL)

Access
Abstract
Slides
Like
Thumbnail

Lipoprotein (a) and cardiovascular risk: are women at increased risk?

Speaker: Doctor M. Santos (Funchal, PT)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster Session 7 - Lipids

Speakers: Professor G. Schwartz, Doctor C. Caselli, Doctor C. Rodriguez, Professor M. Banach, Professor M. Banach...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources